TATE

· Teclison Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for TATE, covering 2024-11-22 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: Combination of TATE and PD-1 Inhibitor in Liver Cancer [Phase 2]